Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

You are viewing the site in preview mode

Skip to main content
Figure 1 | Journal of Translational Medicine

Figure 1

From: Phosphatase of regenerating liver-3 (PRL-3) is associated with metastasis and poor prognosis in gastric carcinoma

Figure 1

Immunohistochemical staining of PRL-3 expression in gastric cancer. A. Negative control; B. PRL-3 mild expression in gastric carcinoma (x200); C. PRL-3 moderate expression in gastric carcinoma (x200); D. Cellular location of PRL-3 expression, mainly localized in the cytomembrane with some granulated loci in cytoplasm (x400, magnification of D.); E. Intense expression of PRL-3 in the primary gastric carcinoma (x200); F. PRL-3 expression in matched liver metastasis developed 2 years after surgery (x200, E and F are from the same patient).

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us